Advanced Bio/Chem Licenses Breast Cancer Biomarker Technology from M.D. Anderson

Mar 16, 2004

NEW YORK, March 16 (GenomeWeb News) - Advanced Bio/Chem has licensed breast cancer protein biomarker technology from the University of Texas' M.D. Anderson Cancer Center, the company said today.

ProteEx, located in The Woodlands, Texas, is doing business as Advanced Bio/Chem.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Not a Unique Challenge Anymore

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Case Goes On

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

The Very Old, Very Young, and Very Talented

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

This Week in PLOS

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.

Main menu